Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists
Prostate cancer is one of the malignant tumors and the second most common malignant tumor in men. Clinically used androgen receptor (AR)–targeted drugs can antagonize androgen and inhibit tumor growth, but these drugs can cause serious resistance problems. To develop novel AR antagonists, 22 kinds o...
Main Authors: | Yueheng Qi, Hong Chen, Shijin Chen, Jianliang Shen, Jingguo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2022.947065/full |
Similar Items
-
Synthesis, biological evaluation, and molecular docking of novel hydroxyzine derivatives as potential AR antagonists
by: Yueheng Qi, et al.
Published: (2022-11-01) -
Discovery of Novel Anti‐Resistance AR Antagonists Guided by Funnel Metadynamics Simulation
by: Haiyi Chen, et al.
Published: (2024-05-01) -
Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation
by: Gonzalo Vera, et al.
Published: (2016-08-01) -
In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
by: Kristina Puls, et al.
Published: (2022-05-01) -
The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2020-08-01)